We have developed a novel DCIL-15-based cancer vaccine platform in which DC specifically express human IL-15 transgene and simultaneously produce tumor Ag fused to human heat shock protein 70 (Aghsp70) as a specific immunogen, and demonstrated its potent antitumor effects in the prophylactic setting.10 Here, RENBP is linked to neoplasm.